Global Organ and Tissue Transplantation Market is valued approximately at USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. The Global Organ and Tissue Transplantation Market refers to the market for transplantation of organs and tissues from one person (donor) to another (recipient) who has damaged or failed organs or tissues. Organ and tissue transplantation is a lifesaving procedure that has revolutionized the treatment of various chronic diseases such as kidney failure, liver cirrhosis, heart failure, lung diseases, and others. The major driving factors for the Global Organ and Tissue Transplantation Market are increasing incidences of chronic diseases and rising healthcare expenditure. Moreover, technological advancement and favorable reimbursement policies are creating lucrative growth opportunities for the market over the forecast period 2022-2029.
There have been several favorable reimbursement policies for organ and tissue transplantation procedures across the world. For instance, in the United States, Medicare covers organ and tissue transplantation procedures for eligible patients. Additionally, several private insurance companies offer coverage for these procedures. Similarly, in Australia, the National Health and Medical Research Council provides funding for organ and tissue transplantation research, and Medicare covers the costs of transplantation procedures for eligible patients. Additionally, in Canada, provincial healthcare plans cover the costs of organ and tissue transplantation procedures for eligible patients. However, the high cost of Organ and Tissue Transplantation stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Organ and Tissue Transplantation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America organ and tissue transplantation market is the dominating in term of revenueglobally due to the presence of advanced healthcare infrastructure, high awareness about transplantation, and favorable reimbursement policies. The US accounts for the majority of the market share in this region. The Asia Pacific market for organ and tissue transplantation is expected to witness fastest growth due to the increasing incidence of chronic diseases, rising healthcare expenditure, and growing awareness about transplantation. China, India, and Japan are the major contributors to the market in this region.
Major market players included in this report are:
- AbbVie Inc.
- Astellas Pharma Inc.
- Bristol-Myers Squibb Company
- Celgene Corporation
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Terumo Corporation
- Zimmer Biomet Holdings, Inc.
Recent Developments in the Market:
- In 2021, Medtronic announced the launch of a new cell processing platform called the Carpediem System, which is designed to improve the quality and availability of kidneys for transplantation. The system is expected to increase the number of kidneys available for transplant by up to 30%.
- OrganOx is a UK-based company that has developed a new technology for preserving and transporting organs for transplantation. In 2020, the company received approval from the US Food and Drug Administration (FDA) for its liver preservation system, which allows for the transportation of livers over longer distances and increases the number of organs available for transplantation.
Global Organ and Tissue Transplantation Market Report Scope:
- Historical Data: - 2020 - 2021
- Base Year for Estimation: - 2022
- Forecast period: - 2023-2030
- Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: - Technology, Application, Type, Source, End-users, Region
- Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Technology:
- Allograft
- Autograft
- Xenograft
- Others
By Application:
- Renal Failure
- Liver Cirrhosis
- Diabetes
- Heart Failure
- Lung Diseases
- Others
By Type:
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Cornea
- Others
By Source:
- Deceased Donors
- Living Donors
- Others
By End-user:
- Hospitals
- Transplant Centers
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Organ and Tissue Transplantation Market, by region, 2020-2030 (USD Billion)
- 1.2.2. Organ and Tissue Transplantation Market, by Technology, 2020-2030 (USD Billion)
- 1.2.3. Organ and Tissue Transplantation Market, by Application, 2020-2030 (USD Billion)
- 1.2.4. Organ and Tissue Transplantation Market, by Type, 2020-2030 (USD Billion)
- 1.2.5. Organ and Tissue Transplantation Market, by Source, 2020-2030 (USD Billion)
- 1.2.6. Organ and Tissue Transplantation Market, by End-user, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Organ and Tissue Transplantation Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Organ and Tissue Transplantation Market Dynamics
- 3.1. Organ and Tissue Transplantation Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing incidence of chronic diseases
- 3.1.1.2. Increasing healthcare expenditure
- 3.1.2. Market Challenges
- 3.1.2.1. High Cost of Organ and Tissue Transplantation
- 3.1.3. Market Opportunities
- 3.1.3.1. Technological advancements
- 3.1.3.2. Favourable reimbursement policies
Chapter 4. Global Organ and Tissue Transplantation Market: Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Organ and Tissue Transplantation Market, by Technology
- 5.1. Market Snapshot
- 5.2. Global Organ and Tissue Transplantation Market by Technology, Performance - Potential Analysis
- 5.3. Global Organ and Tissue Transplantation Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
- 5.4. Organ and Tissue Transplantation Market, Sub Segment Analysis
- 5.4.1. Allograft
- 5.4.2. Autograft
- 5.4.3. Xenograft
- 5.4.4. Others
Chapter 6. Global Organ and Tissue Transplantation Market, by Application
- 6.1. Market Snapshot
- 6.2. Global Organ and Tissue Transplantation Market by Application, Performance - Potential Analysis
- 6.3. Global Organ and Tissue Transplantation Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
- 6.4. Organ and Tissue Transplantation Market, Sub Segment Analysis
- 6.4.1. Renal Failure
- 6.4.2. Liver Cirrhosis
- 6.4.3. Diabetes
- 6.4.4. Heart Failure
- 6.4.5. Lung Diseases
- 6.4.6. Others
Chapter 7. Global Organ and Tissue Transplantation Market, by Type
- 7.1. Market Snapshot
- 7.2. Global Organ and Tissue Transplantation Market by Type, Performance - Potential Analysis
- 7.3. Global Organ and Tissue Transplantation Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
- 7.4. Organ and Tissue Transplantation Market, Sub Segment Analysis
- 7.4.1. Kidney
- 7.4.2. Liver
- 7.4.3. Heart
- 7.4.4. Lung
- 7.4.5. Pancreas
- 7.4.6. Cornea
- 7.4.7. Others
Chapter 8. Global Organ and Tissue Transplantation Market, by Source
- 8.1. Market Snapshot
- 8.2. Global Organ and Tissue Transplantation Market by Source, Performance - Potential Analysis
- 8.3. Global Organ and Tissue Transplantation Market Estimates & Forecasts by Source 2020-2030 (USD Billion)
- 8.4. Organ and Tissue Transplantation Market, Sub Segment Analysis
- 8.4.1. Deceased Donors
- 8.4.2. Living Donors
- 8.4.3. Others
Chapter 9. Global Organ and Tissue Transplantation Market, by End-user
- 9.1. Market Snapshot
- 9.2. Global Organ and Tissue Transplantation Market by End-user, Performance - Potential Analysis
- 9.3. Global Organ and Tissue Transplantation Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
- 9.4. Organ and Tissue Transplantation Market, Sub Segment Analysis
- 9.4.1. Hospitals
- 9.4.2. Transplant Centers
- 9.4.3. Others
Chapter 10. Global Organ and Tissue Transplantation Market, Regional Analysis
- 10.1. Top Leading Countries
- 10.2. Top Emerging Countries
- 10.3. Organ and Tissue Transplantation Market, Regional Market Snapshot
- 10.4. North America Organ and Tissue Transplantation Market
- 10.4.1. U.S. Organ and Tissue Transplantation Market
- 10.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
- 10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 10.4.1.3. Type breakdown estimates & forecasts, 2020-2030
- 10.4.1.4. Source breakdown estimates & forecasts, 2020-2030
- 10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
- 10.4.2. Canada Organ and Tissue Transplantation Market
- 10.5. Europe Organ and Tissue Transplantation Market Snapshot
- 10.5.1. U.K. Organ and Tissue Transplantation Market
- 10.5.2. Germany Organ and Tissue Transplantation Market
- 10.5.3. France Organ and Tissue Transplantation Market
- 10.5.4. Spain Organ and Tissue Transplantation Market
- 10.5.5. Italy Organ and Tissue Transplantation Market
- 10.5.6. Rest of Europe Organ and Tissue Transplantation Market
- 10.6. Asia-Pacific Organ and Tissue Transplantation Market Snapshot
- 10.6.1. China Organ and Tissue Transplantation Market
- 10.6.2. India Organ and Tissue Transplantation Market
- 10.6.3. Japan Organ and Tissue Transplantation Market
- 10.6.4. Australia Organ and Tissue Transplantation Market
- 10.6.5. South Korea Organ and Tissue Transplantation Market
- 10.6.6. Rest of Asia Pacific Organ and Tissue Transplantation Market
- 10.7. Latin America Organ and Tissue Transplantation Market Snapshot
- 10.7.1. Brazil Organ and Tissue Transplantation Market
- 10.7.2. Mexico Organ and Tissue Transplantation Market
- 10.8. Middle East & Africa Organ and Tissue Transplantation Market
- 10.8.1. Saudi Arabia Organ and Tissue Transplantation Market
- 10.8.2. South Africa Organ and Tissue Transplantation Market
- 10.8.3. Rest of Middle East & Africa Organ and Tissue Transplantation Market
Chapter 11. Competitive Intelligence
- 11.1. Key Company SWOT Analysis
- 11.1.1. Company 1
- 11.1.2. Company 2
- 11.1.3. Company 3
- 11.2. Top Market Strategies
- 11.3. Company Profiles
- 11.3.1. AbbVie Inc.
- 11.3.1.1. Key Information
- 11.3.1.2. Overview
- 11.3.1.3. Financial (Subject to Data Availability)
- 11.3.1.4. Product Summary
- 11.3.1.5. Recent Developments
- 11.3.2. Astellas Pharma Inc.
- 11.3.3. Bristol-Myers Squibb Company
- 11.3.4. Celgene Corporation
- 11.3.5. F. Hoffmann-La Roche Ltd
- 11.3.6. Novartis AG
- 11.3.7. Pfizer Inc.
- 11.3.8. Sanofi S.A.
- 11.3.9. Terumo Corporation
- 11.3.10. Zimmer Biomet Holdings, Inc.
Chapter 12. Research Process
- 12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
- 12.2. Research Attributes
- 12.3. Research Assumption